Stock & Company Details
Enliven Therapeutics Inc $ELVN
Price:
N/A
N/A
73M
$3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-24.36
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ELVN technical indicators
Latest Enliven Therapeutics Inc (ELVN) indicator readings as of 2026-10-09.
ELVN's 14-day RSI is 23.8, in oversold territory. At $40.98 it is trading 0.2% below its 200-day moving average of $41.05, and below its 50-day average of $53.99. Price sits near the lower Bollinger Band ($39.35 to $53.86). ADX reads 48.3, indicating a trending market.
Overview
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.
Finance Bot
Ask your questions
Start by typing a question below.
